BCM
RLYB icon

Bridgeway Capital Management’s Rallybio RLYB Stock Holding History

Bridgeway Capital Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,450
Closed -$60K – 1254
2025
Q1 		$60K Hold
11,450
– – ﹤0.01% 1106
2024
Q4 		$87.9K Hold
11,450
– – ﹤0.01% 1122
2024
Q3 		$107K Sell
11,450
-575
-5% -$5.54K ﹤0.01% 1157
2024
Q2 		$129K Hold
12,025
– – ﹤0.01% 1136
2024
Q1 		$178K Sell
12,025
-4,038
-25% -$56.3K ﹤0.01% 1129
2023
Q4 		$307K Buy
16,063
+5,813
+57% +$142K 0.01% 1060
2023
Q3 		$276K Buy
10,250
+8,000
+356% +$347K 0.01% 1030
2023
Q2 		$102K Buy
+2,250
New +$110K ﹤0.01% 1251

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Bridgeway Capital Management's RLYB Position: Q2 2025 in Review

Bridgeway Capital Management sold out of Rallybio (RLYB) in Q2 2025, closing a stake of 11,450 shares — an estimated $60K sold.

Bridgeway Capital Management first reported a position in RLYB in Q2 2023 and held it in 8 quarters. The position peaked at $307K in Q4 2023. 48 funds tracked by Wall St. Rank hold RLYB as of Q2 2025.

  • Bridgeway Capital Management reported no remaining Rallybio position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 11,450 Rallybio shares in Q2 2025, an estimated $60K.
  • Bridgeway Capital Management first reported a position in Rallybio in Q2 2023 and held it in 8 quarters.
  • Bridgeway Capital Management's Rallybio position peaked at $307K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Rallybio as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.